According to the previous literature, Andrographolide inhibits the expression of NF-κB, and as a result, reduces the expression of miR-21-5p, dramatically increasing the target gene expression of programmed cell death protein 4 (PDCD4) to induce apoptosis in breast cancer [82]. This evidence concerns the gene NFKB1 and breast carcinoma.